Literature DB >> 9817740

Mechanisms of immune sensitization of human bronchus.

K F Rabe1.   

Abstract

Bronchial hyperresponsiveness (BHR), the increased sensitivity to a wide variety of stimuli that narrow the airways, is a central abnormality in patients with asthma, and is frequently observed in patients with chronic obstructive pulmonary disease. In the study of the underlying mechanisms of BHR, various animal models have been employed, using methods of active and passive immunization. These studies have led to a changed understanding of smooth muscle hyperreactivity, questioning both the past paradigm of altered neural activity and the modern concepts of inflammation as the single most factor determining BHR, and emphasizing the particular importance of the end organ- the smooth muscle cell. More recently, passive sensitization of human airways has been used by several investigators to describe the mechanisms of allergic sensitization and to study the role of functional abnormalities of human airway smooth muscle, which may represent the key to understanding human BHR, and thus lead to novel treatment approaches for the future.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817740     DOI: 10.1164/ajrccm.158.supplement_2.13tac130

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study.

Authors:  M H Brutsche; S H Downs; C Schindler; M W Gerbase; J Schwartz; M Frey; E W Russi; U Ackermann-Liebrich; P Leuenberger
Journal:  Thorax       Date:  2006-05-02       Impact factor: 9.139

2.  Contractile responses to adenosine, R-PIA and ovalbumen in passively sensitized guinea-pig isolated airways.

Authors:  Timothy J Martin; Kenneth J Broadley
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.

Authors:  Maria G Matera; Luigino Calzetta; Daniela Passeri; Francesco Facciolo; Erino A Rendina; Clive Page; Mario Cazzola; Augusto Orlandi
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 4.  Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models.

Authors:  Luigino Calzetta; Elena Pistocchini; Beatrice Ludovica Ritondo; Francesco Cavalli; Francesca Camardelli; Paola Rogliani
Journal:  Heliyon       Date:  2022-06-22

5.  Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab.

Authors:  Luigino Calzetta; Beatrice Ludovica Ritondo; Maria Gabriella Matera; Francesco Facciolo; Paola Rogliani
Journal:  Br J Pharmacol       Date:  2020-09-17       Impact factor: 8.739

6.  Immune sensitization of equine bronchus: glutathione, IL-1beta expression and tissue responsiveness.

Authors:  M G Matera; L Calzetta; A Peli; A Scagliarini; C Matera; M Cazzola
Journal:  Respir Res       Date:  2005-09-15

7.  Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.

Authors:  Luigino Calzetta; Maria Gabriella Matera; Francesco Facciolo; Mario Cazzola; Paola Rogliani
Journal:  Respir Res       Date:  2018-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.